179 related articles for article (PubMed ID: 8524975)
1. Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans.
Little JT; Broocks A; Martin A; Hill JL; Tune LE; Mack C; Cantillon M; Molchan S; Murphy DL; Sunderland T
Psychopharmacology (Berl); 1995 Aug; 120(3):280-8. PubMed ID: 8524975
[TBL] [Abstract][Full Text] [Related]
2. The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls.
Broocks A; Little JT; Martin A; Minichiello MD; Dubbert B; Mack C; Tune L; Murphy DL; Sunderland T
Biol Psychiatry; 1998 Mar; 43(6):408-16. PubMed ID: 9532345
[TBL] [Abstract][Full Text] [Related]
3. Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.
Broocks A; Briggs NC; Pigott TA; Hill JL; Canter SK; Tolliver TJ; Baldemore D; Murphy DL
Psychopharmacology (Berl); 1997 Mar; 130(2):91-103. PubMed ID: 9106905
[TBL] [Abstract][Full Text] [Related]
4. Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results.
Broocks A; Pigott TA; Hill JL; Canter S; Grady TA; L'Heureux F; Murphy DL
Psychiatry Res; 1998 Jun; 79(1):11-20. PubMed ID: 9676822
[TBL] [Abstract][Full Text] [Related]
5. Serotonin-dependent maintenance of spatial performance and electroencephalography activation after cholinergic blockade: effects of serotonergic receptor antagonists.
Dringenberg HC; Zalan RM
Brain Res; 1999 Aug; 837(1-2):242-53. PubMed ID: 10434009
[TBL] [Abstract][Full Text] [Related]
6. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
Gleason SD; Shannon HE
Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
[TBL] [Abstract][Full Text] [Related]
7. Combined nicotinic and muscarinic blockade in elderly normal volunteers: cognitive, behavioral, and physiologic responses.
Little JT; Johnson DN; Minichiello M; Weingartner H; Sunderland T
Neuropsychopharmacology; 1998 Jul; 19(1):60-9. PubMed ID: 9608577
[TBL] [Abstract][Full Text] [Related]
8. The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates.
Barnes JM; Costall B; Coughlan J; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ; Onaivi ES; Tomkins DM; Tyers MB
Pharmacol Biochem Behav; 1990 Apr; 35(4):955-62. PubMed ID: 2140610
[TBL] [Abstract][Full Text] [Related]
9. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers.
Dukoff R; Wilkinson CW; Lasser R; Friz J; Conway A; Bahro M; Peskind ER; Sunderland T
Biol Psychiatry; 1999 Jul; 46(2):189-95. PubMed ID: 10418693
[TBL] [Abstract][Full Text] [Related]
10. TRH attenuates scopolamine-induced memory impairment in humans.
Molchan SE; Mellow AM; Lawlor BA; Weingartner HJ; Cohen RM; Cohen MR; Sunderland T
Psychopharmacology (Berl); 1990; 100(1):84-9. PubMed ID: 2104988
[TBL] [Abstract][Full Text] [Related]
11. gamma-Aminobutyric acid-serotonin interactions in healthy men: implications for network models of psychosis and dissociation.
D'Souza DC; Gil RB; Zuzarte E; MacDougall LM; Donahue L; Ebersole JS; Boutros NN; Cooper T; Seibyl J; Krystal JH
Biol Psychiatry; 2006 Jan; 59(2):128-37. PubMed ID: 16140281
[TBL] [Abstract][Full Text] [Related]
12. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
Riekkinen P
Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
[TBL] [Abstract][Full Text] [Related]
13. Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans.
Vitiello B; Martin A; Hill J; Mack C; Molchan S; Martinez R; Murphy DL; Sunderland T
Neuropsychopharmacology; 1997 Jan; 16(1):15-24. PubMed ID: 8981385
[TBL] [Abstract][Full Text] [Related]
14. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors.
Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Murphy DL
Psychopharmacology (Berl); 1996 Feb; 123(4):333-9. PubMed ID: 8867872
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression.
Overstreet DH; Daws LC; Schiller GD; Orbach J; Janowsky DS
Pharmacol Biochem Behav; 1998 Apr; 59(4):777-85. PubMed ID: 9586831
[TBL] [Abstract][Full Text] [Related]
16. The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.
Millan MJ; Gobert A; Roux S; Porsolt R; Meneses A; Carli M; Di Cara B; Jaffard R; Rivet JM; Lestage P; Mocaer E; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2004 Oct; 311(1):190-203. PubMed ID: 15146031
[TBL] [Abstract][Full Text] [Related]
17. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.
Benjamin J; Greenberg BD; Murphy DL
Psychopharmacology (Berl); 1996 Sep; 127(2):140-9. PubMed ID: 8888380
[TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity to scopolamine in the elderly.
Flicker C; Ferris SH; Serby M
Psychopharmacology (Berl); 1992; 107(2-3):437-41. PubMed ID: 1615141
[TBL] [Abstract][Full Text] [Related]
19. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.
Sunderland T; Tariot PN; Cohen RM; Weingartner H; Mueller EA; Murphy DL
Arch Gen Psychiatry; 1987 May; 44(5):418-26. PubMed ID: 3579494
[TBL] [Abstract][Full Text] [Related]
20. Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate.
Riekkinen P; Sirviö J; Riekkinen P
Psychopharmacology (Berl); 1991; 103(4):567-70. PubMed ID: 1829538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
